Approximately 70% of metastatic triple-negative breast cancer patients are ineligible for immunotherapy, creating an unmet ...

If we don’t have compassion, we really do need to question what that says about us as individuals and organisations ...

Spyre Therapeutics has appointed Kate Tansey Chevlen as Chief Commercial Officer.

Union Chimique Belge (UCB) has announced the release of new positive data regarding Bimzelx (bimekizumab) in moderate to ...

ASH 2025 showed up with a clenched fist and never loosened it. Under the rallying call of ‘Fight 4 Hematology’, the meeting ...

Gastric cancer is the fifth highest cause of cancer deaths worldwide, with almost a million people diagnosed annually ...

Turn interaction into intelligence! Don’t miss this chance to lead the industry with our free pharma-exclusive webinar!

Over 50 million people across the US live with acne, a condition with no cure that often requires chronic treatment ...

McNamara’s Fallacy is the error of making decisions based solely on easily quantifiable data, while ignoring ...

The current landscape The landscape of dementia clinical trials in Europe is focused on AD, the most common form of dementia.

Boehringer Ingelheim and Simcere have announced a new license and collaboration agreement for the development of SIM0709, a ...

Alzheimer’s disease (AD) continues to be one of the most challenging conditions facing patients, families and healthcare ...